Mizuho Securities USA LLC Takes $2.31 Million Position in Translational Development Acquisition Corp. (NASDAQ:TDACU)

Mizuho Securities USA LLC acquired a new position in shares of Translational Development Acquisition Corp. (NASDAQ:TDACUFree Report) in the fourth quarter, HoldingsChannel reports. The fund acquired 125,000 shares of the company’s stock, valued at approximately $2,305,000.

Several other large investors have also made changes to their positions in the company. Tuttle Capital Management LLC purchased a new stake in Translational Development Acquisition during the fourth quarter worth approximately $461,000. Wealthspring Capital LLC purchased a new stake in Translational Development Acquisition during the 4th quarter worth $1,095,000. Schechter Investment Advisors LLC acquired a new stake in Translational Development Acquisition in the 4th quarter valued at $2,778,000. Periscope Capital Inc. purchased a new position in Translational Development Acquisition in the fourth quarter valued at about $3,688,000. Finally, Picton Mahoney Asset Management acquired a new position in shares of Translational Development Acquisition during the fourth quarter worth about $4,610,000.

Translational Development Acquisition Price Performance

Shares of NASDAQ TDACU opened at $10.14 on Tuesday. Translational Development Acquisition Corp. has a 1-year low of $10.00 and a 1-year high of $10.30. The stock has a 50-day moving average of $10.09.

Translational Development Acquisition Profile

(Free Report)

Trident Acquisitions Corp. does not have significant operations. It intends to enter into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more target businesses primarily in the oil and gas or other natural resource sector.

Further Reading

Want to see what other hedge funds are holding TDACU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Translational Development Acquisition Corp. (NASDAQ:TDACUFree Report).

Institutional Ownership by Quarter for Translational Development Acquisition (NASDAQ:TDACU)

Receive News & Ratings for Translational Development Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Translational Development Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.